Research Use Only. Cagrilintide / Semaglutide Blend is sold as a chemical reagent for in-vitro laboratory research. It is not a drug, supplement, or compounded preparation, and it is not for human or veterinary use. It must be handled by qualified professionals. Wholesale Peptide Supply is not a pharmacy or compounding facility under 503A or 503B.
Wholesale Cagrilintide / Semaglutide Blend — Bulk Research Supply
Buy Cagrilintide / Semaglutide Blend wholesale and in bulk from a US-based research peptide supplier. Every lot is sourced in the USA and third-party tested via HPLC/MS. Bulk Cagrilintide / Semaglutide Blend is quoted by dose and volume from a 100-vial mix-and-match minimum; volume pricing is earned per compound at 100 kits.
A dual-agent research formulation pairing cagrilintide, a long-acting amylin analog, with semaglutide, a long-acting GLP-1 receptor agonist. Studied in laboratory models where amylin and incretin pathway signaling are examined together.
Wholesale Catalog
Available Doses
Published per-vial wholesale pricing for Cagrilintide / Semaglutide Blend. Sold in kits of 10 vials with a 100-vial order minimum you can mix and match across compounds; volume pricing applies at 1,000+ vials. Contact us for larger or custom-volume quotes — typically answered within 10 minutes during business hours.
Cagrilintide / Semaglutide Blend 10mg (5/5)50% off
WPCCS10 · CAS Multi-component · Custom Blends
$51.75$25.88/vial · 50% off at any volumeWhile supplies last
Discontinued — limited to stock on hand. Once it's gone, it's gone. Sold in kits of 10 vials · 100-vial order minimum (mix & match across compounds).
Overview
A dual-agent research formulation pairing cagrilintide, a long-acting amylin analog, with semaglutide, a long-acting GLP-1 receptor agonist. Studied in laboratory models where amylin and incretin pathway signaling are examined together.
History
Combines two separately characterized long-acting analogs whose pathways are frequently compared in published metabolic research, supplied as a single reconstitution for combined-pathway study designs.
Where this sits against the Retatrutide / Cagrilintide blend
The catalogue carries two cagrilintide blends and they share half their composition, so the distinction is worth stating directly. Both pair 5 mg of cagrilintide, a long-acting amylin analogue, with 5 mg of an incretin-pathway agonist. What changes is the partner.
This blend uses semaglutide, which is active at a single receptor: GLP-1. The Retatrutide / Cagrilintide blend uses retatrutide, which is active at three — GLP-1, GIP and glucagon. The amylin arm is held constant across both.
That makes the two useful alongside one another rather than as substitutes. Run against each other they isolate how many incretin pathways are co-activated beside amylin signalling, with the amylin component unchanged between them. Ordering one where the design called for the other changes the receptor coverage of half the preparation.
Key Areas of Research
- Amylin receptor pathway signaling
- GLP-1 receptor pathway signaling
- Combined vs. single-pathway comparative models
References
- Lau J. et al. (2015). Discovery of the once-weekly GLP-1 analog semaglutide. J Med Chem, 58(18):7370–7380.
- Enebo L.B. et al. (2021). Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant cagrilintide and semaglutide. Lancet, 397(10286):1736–1748.
Cagrilintide / Semaglutide Blend — Frequently Asked Questions
- What is Cagrilintide / Semaglutide Blend?
- A dual-agent research formulation pairing cagrilintide, a long-acting amylin analog, with semaglutide, a long-acting GLP-1 receptor agonist. Studied in laboratory models where amylin and incretin pathway signaling are examined together.
- What doses of Cagrilintide / Semaglutide Blend are available wholesale?
- Wholesale Peptide Supply stocks Cagrilintide / Semaglutide Blend in 10mg (5/5). Wholesale pricing is provided by quote based on order volume across 100–1,000 vials.
- Is Cagrilintide / Semaglutide Blend third-party tested?
- Yes. Every lot of Cagrilintide / Semaglutide Blend is tested by an independent third-party laboratory using HPLC/MS, and a per-lot Certificate of Analysis documenting identity and purity is included with every order at no charge, issued in the name of Wholesale Peptide Supply.
- Is Cagrilintide / Semaglutide Blend for human use?
- No. Cagrilintide / Semaglutide Blend is sold strictly as a chemical reagent for in-vitro laboratory research and is not for human or veterinary use. Wholesale Peptide Supply is not a pharmacy or compounding facility.
- How do I get wholesale pricing for Cagrilintide / Semaglutide Blend?
- Request a quote through our contact form or open a wholesale account. An account manager replies with volume pricing and lead times, typically within 10 minutes during business hours.
- Can I order Cagrilintide / Semaglutide Blend in bulk?
- Yes. Cagrilintide / Semaglutide Blend is available for bulk and wholesale orders, quoted by dose and volume, with the lower price earned per compound at 100 kits (1,000 vials). Submit the doses and quantities you need for a bulk quote.
Related Compounds
Custom Blends
GLOW Blend
The GLOW Blend combines GHK-Cu, BPC-157, and TB-500 in a single research formulation, studied across structural, epithelial, vascular, and systemic models.
View details →Custom Blends
KLOW Blend
The KLOW Blend extends the GLOW formulation with the addition of KPV, adding cytokine-modulating and immune signaling properties to the structural and vascular base blend.
View details →Custom Blends
Retatrutide / Cagrilintide Blend
A dual-agent research formulation pairing retatrutide, a triple-pathway receptor agonist, with cagrilintide, a long-acting amylin analog. Studied where triple-agonist and amylin pathway signaling are examined together.
View details →Custom Blends
Semax / Selank Blend
A research formulation pairing Semax, an ACTH(4-10) analog, with Selank, a tuftsin analog. Both are Russian-developed regulatory peptides and are frequently studied side by side in neuropeptide research.
View details →GLP-1 & Metabolic
Semaglutide
Semaglutide is a synthetic peptide analog that functions as a long-acting pathway agonist, structurally modified for extended half-life and improved target binding affinity. It is studied in preclinical and laboratory models for its ability to activate target pathways and modulate downstream molecular signaling associated with endocrine regulation.
View details →GLP-1 & Metabolic
Tirzepatide
Tirzepatide is a synthetic peptide that functions as a dual pathway agonist, designed as a once-weekly investigational compound studied in preclinical laboratory models for receptor-mediated signaling and modulation of downstream cascades.
View details →GLP-1 & Metabolic
Retatrutide
Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds. It activates multiple target receptor subtypes for broad systemic effects studied in preclinical models.
View details →Growth Hormone
Ipamorelin
Ipamorelin is a synthetic pentapeptide and selective secretagogue-type agonist with minimal off-target pathway interference, used to study endocrine signaling and somatotroph axis modulation.
View details →